by The global Sperm Count Test Market is estimated to be valued at US$ 517.5 Mn in 2023 and is expected to exhibit a CAGR of 12.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
A sperm count test measures the concentration of sperm in a man’s semen or ejaculate. It is done to check fertility and determine the cause of infertility issues. A normal sperm count is important for natural conception and a healthy pregnancy.
Market key trends:
The increasing prevalence of male infertility due to changing lifestyle and rising environmental pollution is a major driver for the sperm count test market. As per the World Health Organization (WHO), nearly 50% of infertility cases can be attributed to male factors and around 10-15% of couples worldwide face infertility problems. Furthermore, the growing awareness about male fertility and availability of advanced sperm testing kits for home use is also fueling the demand for sperm count tests globally. However, the low adoption in developing nations continues to restrain the market growth.
SWOT Analysis
Strength: The sperm count test market has high growth prospects due to increasing male infertility rates worldwide. Advancing technologies enable accurate and easy-to-use home sperm testing kits.
Weakness: Lack of awareness about male infertility in some emerging markets. High cost of advanced sperm testing devices limits their adoption in low-income countries.
Opportunity: Growing health awareness and male participation in family planning presents an opportunity to provide more affordable sperm testing solutions. Telehealth can help expand access to fertility consultations and sperm analysis in rural areas.
Threats: Privacy and data security threats associated with sperm sample collection and analysis using connected devices. Competition from other fertility and pregnancy test kits may divert consumer spending away from sperm tests.
Key Takeaways
The global Sperm Count Test Market Share is expected to witness high growth, exhibiting CAGR of 12% over the forecast period, due to increasing male infertility rates worldwide. Advancements in diagnostics have enabled development of accurate, easy-to-use home sperm testing kits which is driving market growth.
Regional analysis: North America region currently dominates the sperm count test market owing to well-established healthcare infrastructure and high awareness levels about infertility issues. Asia Pacific is expected to exhibit fastest growth during the forecast period supported by growing medical tourism, rising healthcare expenditure and large patient pool in China and India.
Key players operating in the Sperm Count Test market are LLC Medical Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics, bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA, SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife, Welling Home
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
